PR releases

PR- Ubiquisys secures B Round funding for breakthrough Femtocell technology

SWINDON, UK - July 20th 2007 - Ubiquisys Ltd, pioneer of intelligent 3G femtocell access points for the residential market, today announced it has secured B-round funding totalling $25m. The company's A-round backers- leading technology investors Accel Partners, Atlas Venture and Advent Venture Partners - have been joined by search engine Google in the investment.

The Ubiquisys ZoneGate femtocell offers mobile users high-quality mobile coverage in the home using their usual 3G cell phones. The device plugs into an existing home broadband gateway or is built into a gateway product that includes WiFi, DSL, Ethernet, phone ports and USB.

'Our mission is to empower mobile carriers to bring compelling service packages into homes using our ZoneGate solution,' said Chris Gilbert, CEO Ubiquisys. 'We're delighted by the confidence our investors have shown in our technology and its ability to deliver innovative applications via ZoneGate's unique services platform.'

About Ubiquisys Ltd
Ubiquisys is a privately owned communications company formed in 2004 to bring the ground breaking ZoneGate femtocell technology to market. In June 2007 independent analysts ABI Research ranked Ubiquisys number one femtocell vendor. It was the first vendor to demonstrate a fully working femtocell solution at 3GSM World Congress 2006 and a year later unveiled the world's first commercial grade femtocell system. The company was recently named a Red Herring Europe 100 Winner. For more information, visit www.ubiquisys.com

Ubiquisys founded the Femto Forum to support and promote the uptake of femtocell technologies worldwide. It is an independent, not-for-profit membership organisation whose membership includes many leading operators and vendors. For more information, visit www.femtoforum.org

About Femtocells
Poor indoor coverage often prevents mobile customers using cell phone services at home and is impeding take-up of multimedia 3G offerings. Ubiquisys was formed in 2004 to address this challenge by bringing its innovative ZoneGate femtocell technology to market. The ZoneGate femtocell is a small 'zero-touch' plug-and-play device that plugs into a home broadband connection and provides high-quality 3G coverage in the home. Unlike WiFi, ZoneGate allows people to use their usual 3G cell phones to access services. ZoneGate means excellent mobile coverage at landline rates and allows mobile carriers to deliver innovative new services right where their customers need them - in their homes.

The ZoneGate system is unique in applying a standards-based approach to network integration by supporting both UMA and SIP/IMS protocols.

About Accel Partners:
Founded in 1983, Accel Partners is one of the world's leading venture capital firms. The firm is dedicated to partnering with outstanding entrepreneurs to build world-class Internet, software and networking companies. Accel Partners has more than $4bn under management from its offices in Palo Alto, London, and China, and its portfolio companies have completed IPOs that have created well over $150 billion in market capitalisation. Representative current and former investments include Brightcove, Comscore, Double Fusion, Facebook, Glam, Macromedia and RealNetworks. For more information, please visit www.Accel.com

About Advent Ventures
Advent Ventures is one of the most experienced technology venture capital firms in Europe. Established in 1981 in the UK, it invests in both the Technology and Life Sciences sectors. Advent Ventures has over £500 million ($1 billion) under management from institutional investors across Europe and the USA. Advent portfolio company Cartesis was recently sold to Business Objects for $300 million. Other Technology investments include Snell & Wilcox (leading digital media infrastructure technology supplier), BridgeCo (Silicon for digital media home networking) and Qype (local search and user-generated city guide. For more information, visit www.adventventures.com

About Atlas Venture
Atlas Venture is a leading early-stage venture capital firm that invests in technology and life sciences companies. Since inception in 1980, we have helped build over 300 companies in more than 16 different countries. In the past decade, 44 portfolio companies have been acquired and 47 are now public companies with an aggregate market capitalisation of over $15 billion. The firm is currently investing from its seventh fund and manages over $2.5 billion in committed capital. For more information, please visit http://www.atlasventure.com